Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Language
Publication year range
1.
J Psychiatr Res ; 113: 181-189, 2019 06.
Article in English | MEDLINE | ID: mdl-30981159

ABSTRACT

Studies have suggested the involvement of oxidative stress in the physiopathology of bipolar disorder. Preclinical data have shown that PKC inhibitors may act as mood-stabilizing agents and protect the brain in animal models of mania. The present study aimed to evaluate the effects of Lithium (Li) or tamoxifen (TMX) on behavioral changes and oxidative stress parameters in an animal model of mania induced by ouabain (OUA). Wistar rats received a single intracerebroventricular (ICV) injection of OUA or artificial cerebrospinal fluid (ACSF). From the day following ICV injection, the rats were treated for seven days with intraperitoneal injections of saline, Li or TMX twice a day. On the 7th day after OUA injection, locomotor activity was measured using the open-field test, and the oxidative stress parameters were evaluated in the hippocampus and frontal cortex of rats. The results showed that OUA induced hyperactivity in rats, which is considered a manic-like behavior. Also, OUA increased lipid peroxidation and oxidative damage to proteins, as well as causing alterations to antioxidant enzymes in the frontal cortex and hippocampus of rats. The Li or TMX treatment reversed the manic-like behavior induced by OUA. Besides, Li, but not TMX, reversed the oxidative damage caused by OUA. These results suggest that the manic-like effects induced by OUA and the antimanic effects of TMX seem not to be related to the oxidative stress.


Subject(s)
Antimanic Agents/pharmacology , Bipolar Disorder/drug therapy , Brain/drug effects , Brain/physiopathology , Oxidative Stress , Tamoxifen/pharmacology , Animals , Bipolar Disorder/physiopathology , Disease Models, Animal , Male , Ouabain/administration & dosage , Rats , Rats, Wistar , Selective Estrogen Receptor Modulators/pharmacology
2.
Mol Neurobiol ; 56(4): 2379-2393, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30027342

ABSTRACT

The present study evaluated the effects of AR-A014418 on behavioral and oxidative stress parameters of rats submitted to the animal model of mania induced by ouabain (OUA). Wistar rats were submitted to stereotaxic surgery and received a single intracerebroventricular (ICV) injection of artificial cerebrospinal fluid (aCSF), OUA, or AR-A014418. After 7 days, the animals were submitted to open-field test. After behavioral analysis, the brains were dissected in frontal cortex and hippocampus to the evaluation of oxidative stress. The OUA induced manic-like behavior in rats, which was reversed by AR-A014418 treatment. The ICV administration of OUA increases the levels of superoxide in submitochondrial particles, lipid hydroperoxide (LPH), 4-hydroxynonenal (4-HNE), 8-isoprostane, protein carbonyl, 3-nitrotyrosine, and activity of superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione reductase (GR) in both structures evaluated. In general, the treatment with AR-A014418 reversed these effects of OUA on the submitochondrial particles, LPH, 4-HNE, 8-isoprostane, protein carbonyl, 3-nitrotyrosine levels, and SOD activity. Furthermore, the injection of OUA decreased the catalase activity, and AR-A014418 promoted an increase in activity of this enzyme in the brain structures. These results suggest that GSK-3ß inhibition can modulate manic-like behaviors. Also, it can be suggested that inhibition of GSK-3ß can be effective against oxidative stress. However, more studies are needed to better elucidate these mechanisms. Graphical Abstract The effects of AR-A014418 on the behavioral and oxidative stress parameters in the animal model of mania induced by ouabain. Superoxide = superoxide production in submitochondrial particles; LPH = lipid hydroperoxide; 4-HNE = 4-hydroxynonenal; SOD = superoxide dismutase; GPx = glutathione peroxidase; GR = glutathione reductase.


Subject(s)
Behavior, Animal , Bipolar Disorder/enzymology , Bipolar Disorder/pathology , Glycogen Synthase Kinase 3 beta/antagonists & inhibitors , Oxidative Stress , Aldehydes/metabolism , Animals , Antioxidants/metabolism , Behavior, Animal/drug effects , Bipolar Disorder/physiopathology , Catalase/metabolism , Dinoprost/analogs & derivatives , Dinoprost/metabolism , Disease Models, Animal , Glutathione Peroxidase/metabolism , Glycogen Synthase Kinase 3 beta/metabolism , Lipid Peroxidation/drug effects , Male , Motor Activity/drug effects , Oxidative Stress/drug effects , Protein Carbonylation/drug effects , Rats, Wistar , Submitochondrial Particles/drug effects , Submitochondrial Particles/metabolism , Superoxide Dismutase/metabolism , Superoxides/metabolism , Thiazoles/administration & dosage , Thiazoles/pharmacology , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Urea/administration & dosage , Urea/analogs & derivatives , Urea/pharmacology
3.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 40(4): 367-375, Oct.-Dec. 2018. graf
Article in English | LILACS | ID: biblio-959251

ABSTRACT

Objective: To evaluate the effects of Hypericum perforatum (hypericum) on cognitive behavior and neurotrophic factor levels in the brain of male and female rats. Methods: Male and female Wistar rats were treated with hypericum or water during 28 days by gavage. The animals were then subjected to the open-field test, novel object recognition and step-down inhibitory avoidance test. Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell-line derived neurotrophic factor (GDNF) levels were evaluated in the hippocampus and frontal cortex. Results: Hypericum impaired the acquisition of short- and long-term aversive memory in male rats, evaluated in the inhibitory avoidance test. Female rats had no immediate memory acquisition and decreased short-term memory acquisition in the inhibitory avoidance test. Hypericum also decreased the recognition index of male rats in the object recognition test. Female rats did not recognize the new object in either the short-term or the long-term memory tasks. Hypericum decreased BDNF in the hippocampus of male and female rats. Hypericum also decreased NGF in the hippocampus of female rats. Conclusions: The long-term administration of hypericum appears to cause significant cognitive impairment in rats, possibly through a reduction in the levels of neurotrophic factors. This effect was more expressive in females than in males.


Subject(s)
Animals , Male , Female , Plant Extracts/pharmacology , Cognition/drug effects , Hypericum , Frontal Lobe/metabolism , Hippocampus/metabolism , Nerve Growth Factors/analysis , Plant Extracts/administration & dosage , Random Allocation , Sex Factors , Treatment Outcome , Rats, Wistar , Models, Animal , Pattern Recognition, Physiological/drug effects , Dose-Response Relationship, Drug , Frontal Lobe/drug effects , Hippocampus/drug effects , Locomotion/drug effects , Memory/drug effects , Nerve Growth Factors/drug effects
4.
Braz J Psychiatry ; 40(4): 367-375, 2018.
Article in English | MEDLINE | ID: mdl-30110089

ABSTRACT

OBJECTIVE: To evaluate the effects of Hypericum perforatum (hypericum) on cognitive behavior and neurotrophic factor levels in the brain of male and female rats. METHODS: Male and female Wistar rats were treated with hypericum or water during 28 days by gavage. The animals were then subjected to the open-field test, novel object recognition and step-down inhibitory avoidance test. Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell-line derived neurotrophic factor (GDNF) levels were evaluated in the hippocampus and frontal cortex. RESULTS: Hypericum impaired the acquisition of short- and long-term aversive memory in male rats, evaluated in the inhibitory avoidance test. Female rats had no immediate memory acquisition and decreased short-term memory acquisition in the inhibitory avoidance test. Hypericum also decreased the recognition index of male rats in the object recognition test. Female rats did not recognize the new object in either the short-term or the long-term memory tasks. Hypericum decreased BDNF in the hippocampus of male and female rats. Hypericum also decreased NGF in the hippocampus of female rats. CONCLUSIONS: The long-term administration of hypericum appears to cause significant cognitive impairment in rats, possibly through a reduction in the levels of neurotrophic factors. This effect was more expressive in females than in males.


Subject(s)
Cognition/drug effects , Frontal Lobe/metabolism , Hippocampus/metabolism , Hypericum , Nerve Growth Factors/analysis , Plant Extracts/pharmacology , Animals , Dose-Response Relationship, Drug , Female , Frontal Lobe/drug effects , Hippocampus/drug effects , Locomotion/drug effects , Male , Memory/drug effects , Models, Animal , Nerve Growth Factors/drug effects , Pattern Recognition, Physiological/drug effects , Plant Extracts/administration & dosage , Random Allocation , Rats, Wistar , Sex Factors , Treatment Outcome
5.
Mol Neurobiol ; 55(2): 1430-1439, 2018 02.
Article in English | MEDLINE | ID: mdl-28168425

ABSTRACT

Studies have suggested the involvement of inflammatory processes in the physiopathology of bipolar disorder. Preclinical evidences have shown that histone deacetylase inhibitors may act as mood-stabilizing agents and protect the brain in models of mania and depression. The aim of the present study was to evaluate the effects of sodium butyrate (SB) and valproate (VPA) on behavioral changes, histone deacetylase activity, and the levels of cytokines in an animal model of mania induced by dextroamphetamine (d-AMPH). Wistar rats were first given d-AMPH or saline (Sal) for a period of 14 days, and then, between the 8th and 14th days, the rats were treated with SB, VPA, or Sal. The activity of histone deacetylase and the levels of cytokines (interleukin (IL) IL-4, IL-6, and IL-10 and tumor necrosis factor-alpha (TNF-α)) were evaluated in the frontal cortex and striatum of the rats. The administration of d-AMPH increased the activity of histone deacetylase in the frontal cortex. Administration of SB or VPA decreased the levels of histone deacetylase activity in the frontal cortex and striatum of rats. SB per se increased the levels of cytokines in both of the brain structures evaluated. AMPH increased the levels of cytokines in both of the brain structures evaluated, and VPA reversed this alteration. The effects of SB on d-AMPH-induced cytokine alterations were dependent on the brain structure and the cytokine evaluated. Despite VPA and SB having a similar mechanism of action, both being histone deacetylase inhibitors, they showed different effects on the levels of cytokines. The present study reinforces the need for more research into histone deacetylase inhibitors being used as a possible target for new medications in the treatment of bipolar disorder.


Subject(s)
Antimanic Agents/pharmacology , Bipolar Disorder/drug therapy , Brain/drug effects , Cytokines/metabolism , Histone Deacetylase Inhibitors/pharmacology , Histone Deacetylases/metabolism , Animals , Antimanic Agents/therapeutic use , Bipolar Disorder/chemically induced , Bipolar Disorder/metabolism , Brain/metabolism , Dextroamphetamine , Disease Models, Animal , Histone Deacetylase Inhibitors/therapeutic use , Male , Motor Activity/drug effects , Rats , Rats, Wistar
6.
Int J Neuropsychopharmacol ; 20(11): 877-885, 2017 11 01.
Article in English | MEDLINE | ID: mdl-29020306

ABSTRACT

Background: The intracerebroventricular injection of ouabain, a specific inhibitor of the Na+/K+-adenosine-triphosphatase (Na+/K+-ATPase) enzyme, induces hyperactivity in rats in a putative animal model of mania. Several evidences have suggested that the protein kinase C signaling pathway is involved in bipolar disorder. In addition, it is known that protein kinase C inhibitors, such as lithium and tamoxifen, are effective in treating acute mania. Methods: In the present study, we investigated the effects of lithium and tamoxifen on the protein kinase C signaling pathway in the frontal cortex and hippocampus of rats submitted to the animal model of mania induced by ouabain. We showed that ouabain induced hyperlocomotion in the rats. Results: Ouabain increased the protein kinase C activity and the protein kinase C and MARCKS phosphorylation in frontal cortex and hippocampus of rats. Lithium and tamoxifen reversed the behavioral and protein kinase C pathway changes induced by ouabain. These findings indicate that the Na+/K+-ATPase inhibition can lead to protein kinase C alteration. Conclusions: The present study showed that lithium and tamoxifen modulate changes in the behavior and protein kinase C signalling pathway alterations induced by ouabain, underlining the need for more studies of protein kinase C as a possible target for treatment of bipolar disorder.


Subject(s)
Antidepressive Agents/therapeutic use , Bipolar Disorder/chemically induced , Enzyme Inhibitors/toxicity , Lithium/therapeutic use , Ouabain/toxicity , Protein Kinase C/metabolism , Tamoxifen/therapeutic use , Analysis of Variance , Animals , Bipolar Disorder/pathology , Brain/drug effects , Brain/enzymology , Disease Models, Animal , Drug Administration Routes , Locomotion/drug effects , Locomotion/physiology , Male , Rats , Rats, Wistar
7.
Bipolar Disord ; 19(4): 246-258, 2017 06.
Article in English | MEDLINE | ID: mdl-28612976

ABSTRACT

OBJECTIVES: The goal of the present study was to investigate the effects of lithium administration on behavior, oxidative stress parameters and cytokine levels in the periphery and brain of mice subjected to an animal model of mania induced by paradoxical sleep deprivation (PSD). METHODS: Male C57 mice were treated with saline or lithium for 7 days. The sleep deprivation protocol started on the 5th day during for the last 36 hours of the treatment period. Immediately after the sleep deprivation protocol, animals locomotor activity was evaluated and serum and brain samples was extracted to evaluation of corticosterone and adrenocorticotropic hormone circulating levels, oxidative stress parameters and citokynes levels. RESULTS: The results showed that PSD induced hyperactivity in mice, which is considered a mania-like behavior. PSD increased lipid peroxidation and oxidative damage to DNA, as well as causing alterations to antioxidant enzymes in the frontal cortex, hippocampus and serum of mice. In addition, PSD increased the levels of cytokines in the brains of mice. Treatment with lithium prevented the mania-like behavior, oxidative damage and cytokine alterations induced by PSD. CONCLUSIONS: Improving our understanding of oxidative damage in biomolecules, antioxidant mechanisms and the inflammatory system - alterations presented in the animal models of mania - is important in helping us to improve our knowledge concerning the pathophysiology of BD, and the mechanisms of action employed by mood stabilizers.


Subject(s)
Bipolar Disorder , Brain/metabolism , Cytokines/blood , Lithium Compounds/pharmacology , Oxidative Stress , Sleep Deprivation/complications , Adrenocorticotropic Hormone/blood , Animals , Antimanic Agents/pharmacology , Behavior, Animal/drug effects , Bipolar Disorder/etiology , Bipolar Disorder/metabolism , Corticosterone/blood , Disease Models, Animal , Hyperkinesis/metabolism , Hyperkinesis/prevention & control , Lipid Peroxidation/drug effects , Male , Mice , Oxidative Stress/drug effects , Oxidative Stress/physiology , Physical Exertion/drug effects , Treatment Outcome
8.
Neuropharmacology ; 117: 447-459, 2017 05 01.
Article in English | MEDLINE | ID: mdl-27789311

ABSTRACT

The present study aimed to investigate the effects of mood stabilizers, specifically lithium (Li) and valproate (VPA), on the PI3K/Akt signaling pathway in the brains of rats subjected to the ouabain (OUA)-induced animal model of mania. In addition, the effects of AR-A014418, a GSK-3ß inhibitor, on manic-like behavior induced by OUA were evaluated. In the first experimental protocol Wistar rats received a single ICV injection of OUA or artificial cerebrospinal fluid (aCSF). From the day following ICV injection, the rats were treated for 6 days with intraperitoneal injections of saline, Li or VPA twice a day. In the second experimental protocol, rats received OUA, aCSF, OUA plus AR-A014418, or aCSF plus AR-A014418. On the 7th day after OUA injection, locomotor activity was measured using the open-field test. In addition, we analyzed the levels of p-PI3K, p-MAPK, p-Akt, and p-GSK-3ß in the brain of rats by immunoblot. Li and VPA reversed OUA-related hyperactivity. OUA decreased p-PI3K, p-Akt and p-GSK-3ß levels. Li and VPA improved these OUA-induced cellular dysfunctions; however, the effects of the mood stabilizers were dependent on the protein and brain region analyzed. In addition, AR-A014418 reversed the manic-like behavior induced by OUA. These findings suggest that the manic-like effects of ouabain are associated with the activation of GSK-3ß, and that Li and VPA exert protective effects against OUA-induced inhibition of the GSK-3ß pathway.


Subject(s)
Antimanic Agents/pharmacology , Bipolar Disorder/drug therapy , Glycogen Synthase Kinase 3 beta/metabolism , Lithium Compounds/pharmacology , Valproic Acid/pharmacology , Animals , Bipolar Disorder/enzymology , Disease Models, Animal , Frontal Lobe/drug effects , Frontal Lobe/enzymology , Glycogen Synthase Kinase 3 beta/antagonists & inhibitors , Hippocampus/drug effects , Hippocampus/enzymology , Locomotion/drug effects , Locomotion/physiology , Male , Ouabain , Phosphatidylinositol 3-Kinases/metabolism , Phosphorylation/drug effects , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Rats, Wistar , Signal Transduction/drug effects , Thiazoles/pharmacology , Urea/analogs & derivatives , Urea/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...